Niyikiza Clet M. 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed Feb 6, 2013
Insider Transaction Report
Form 4
Niyikiza Clet M.
EVP of Development
Transactions
- Exercise/Conversion
Common Stock
2013-02-05$2.12/sh+41,507$87,995→ 141,507 total - Exercise/Conversion
Stock Option (right to buy)
2013-02-05−41,507→ 58,493 totalExercise: $2.12Exp: 2019-11-04→ Common Stock (41,507 underlying)
Footnotes (1)
- [F1]This option is fully vested.